Jim McSweeney is Omeza’s Director of Sales East, leading eastern region key account managers and developing strategy for and developing strategy for account acquisition.
Jim worked for 3M/KCI from 2018 to 2021, most recently as Director of Corporate Accounts. He began his career at Novartis, progressing to Senior Account Specialist in the Specialty Tissue Engineering Division which was sold to Organogenesis in 2003. He became Regional Sales Manager for Organogenesis, building sales for their Apligraf® Tissue Substitute product before leaving to join advanced wound care startup Spiracur, Inc. in 2012 as Regional Sales Manager Northeast. There, he helped launch the novel Negative Pressure Wound Treatment called SNAP®.
He earned his Bachelor’s degree in Business and Managerial Economics from the University of Connecticut.